IRulya Therapeutics (IRLA) Ending Cash Balance (2018 - 2026)
IRulya Therapeutics' Ending Cash Balance was $115.98 million in Q2 2026, up 589.3% from $16.83 million a year earlier and up 538.6% from the prior quarter.
Powered by 
Analysis
IRulya Therapeutics (IRLA) Ending Cash Balance (2018 - 2026) Analysis & Trends
For FY2025, Ending Cash Balance at IRulya Therapeutics came in at $5.81 million, down 6.5% from FY2024.
- Ending Cash Balance has now declined for three consecutive years, with a three-year compound annual growth rate of -49.3% (FY2022 to FY2025).
- In earlier years, Ending Cash Balance was $6.21 million in FY2024 (-70.1%), $20.75 million in FY2023 (-53.4%) and $44.58 million in FY2022.
- The Q2 2026 figure marks the highest quarterly Ending Cash Balance in data going back to Q4 2018.
- Compared with a year earlier, Ending Cash Balance was higher in four of the last eight quarters, with growth averaging 93.6%.
- The best year-over-year quarter for Ending Cash Balance over five years was Q2 2026 (growth of 589.3%); the worst was Q3 2024 (a decline of 87.6%).
- Per Business Quant data, IRLA's Ending Cash Balance in the three quarters before Q2 2026 was $18.16 million (Q1 2026), $5.81 million (Q4 2025) and $6.45 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 1.88 Bn |
| 10 | IRulya Therapeutics | 207.35 Mn | 91.35 Mn | - | 115.98 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 115.98 Mn |
| Mar 31, 2026 | 18.16 Mn |
| Dec 31, 2025 | 5.81 Mn |
| Sep 30, 2025 | 6.45 Mn |
| Jun 30, 2025 | 16.83 Mn |
| Mar 31, 2025 | 7.77 Mn |
| Dec 31, 2024 | 6.21 Mn |
| Sep 30, 2024 | 2.68 Mn |
| Jun 30, 2024 | 7.89 Mn |
| Mar 31, 2024 | 21.81 Mn |
| Dec 31, 2023 | 20.75 Mn |
| Sep 30, 2023 | 21.63 Mn |
| Jun 30, 2023 | 22.65 Mn |
| Dec 31, 2022 | 44.58 Mn |
| Dec 31, 2019 | 51.21 Mn |
| Dec 31, 2018 | 24.87 Mn |
API Access
IRulya Therapeutics Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=IRLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "IRLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=IRLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();